Biosimilars - Impact for Patients | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Biosimilars - Impact for Patients

Managing Your Treatment
Presentation Date: 
Tue, 11/12/2019 - 7:00pm (EST)

In this webinar, Cate Lockhart - Executive Director at Biologics and Biosimilars Collective Intelligence Consortium, helps patients and families understand the difference between biologic and biosimilar medications. She discusses the approval process for FDA approval and how biosimiliar medications will impact the future of treating patients.